Improved DNA vaccine delivery with needle-free injection systems

C Ledesma-Feliciano, R Chapman, JW Hooper… - Vaccines, 2023 - mdpi.com
DNA vaccines have inherent advantages compared to other vaccine types, including safety,
rapid design and construction, ease and speed to manufacture, and thermostability …

The development of DNA vaccines against SARS-CoV-2

K Khalid, CL Poh - Advances in Medical Sciences, 2023 - Elsevier
Background The COVID-19 pandemic exerted significant impacts on public health and
global economy. Research efforts to develop vaccines at warp speed against SARS-CoV-2 …

Immunogenicity of candidate MERS-CoV DNA vaccines based on the spike protein

SS Al-Amri, AT Abbas, LA Siddiq, A Alghamdi… - Scientific reports, 2017 - nature.com
MERS-coronavirus is a novel zoonotic pathogen which spread rapidly to> 25 countries since
2012. Its apparent endemicity and the wide spread of its reservoir host (dromedary camels) …

[HTML][HTML] A contemporary review on the important role of in silico approaches for managing different aspects of COVID-19 crisis

M Moradi, R Golmohammadi, A Najafi… - Informatics in Medicine …, 2022 - Elsevier
In the last century, the emergence of in silico tools has improved the quality of healthcare
studies by providing high quality predictions. In the case of COVID-19, these tools have …

Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector

S Peng, HF Tu, M Cheng, MH Hu, HL Tsai, YC Tsai… - Mbio, 2023 - Am Soc Microbiol
Intramuscular vaccination of mice with the naked pBI-11 DNA plasmid targeting E6 and E7
of HPV16 and HPV18 via a conventional syringe and needle generates human …

DNA based vaccine expressing SARS-CoV-2 Spike-CD40L fusion protein confers protection against challenge in a Syrian hamster model

LA Tamming, D Duque, A Tran, W Zhang… - Frontiers in …, 2022 - frontiersin.org
SARS-CoV-2 infections present a tremendous threat to public health. Safe and efficacious
vaccines are the most effective means in preventing the infections. A variety of vaccines …

SARS-CoV-2 doggybone DNA vaccine produces cross-variant neutralizing antibodies and is protective in a COVID-19 animal model

EM Mucker, RL Brocato, LM Principe, RK Kim, X Zeng… - Vaccines, 2022 - mdpi.com
To combat the COVID-19 pandemic, an assortment of vaccines has been developed.
Nucleic acid vaccines have the advantage of rapid production, as they only require a viral …

Duck CD40L as an adjuvant enhances systemic immune responses of avian flavivirus DNA vaccine

J Huang, G Luo, W Wang, Y Lu, M Wang, M Liu, D Zhu… - npj Vaccines, 2024 - nature.com
Under the dual pressure of emerging zoonoses and the difficulty in eliminating conventional
zoonoses, the strategic management of bird diseases through vaccination represents a …

Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animals

ND Aljehani, L Tamming, MY Khan, RH Abdulal… - mBio, 2024 - journals.asm.org
The COVID-19 pandemic has emphasized the importance and need for accessible safe,
effective, and versatile vaccine platforms. While approved SARS-CoV-2 vaccines have been …

[HTML][HTML] Pre-existing Immunity to Endemic Human Coronaviruses Does Not Affect the Immune Response to SARS-CoV-2 Spike in a Murine Vaccination Model

AY Jeong, P Lee, MS Lee, DJ Kim - Immune Network, 2023 - ncbi.nlm.nih.gov
Endemic human coronaviruses (HCoVs) have been evidenced to be cross-reactive to
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although a correlation …